New Year and Chrismas Offer
Digital PCR-dPCR Market

Digital PCR-dPCR Market Size, Share & Segmentation by Technology Type (Droplet Digital PCR, Chip Based Digital PCR, Beaming Digital PCR), by Product (Igital PCR Systems, Consumables and Reagents, Software And Services), by Application (Clinical Diagnostics, Forensic And Others), by End Use (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories, Universities And Other Organizations), and by Region | Global Market Forecast 2022-2028

Report Id: SNS/HC/1038 | May 2022 | Region: Global | 125 Pages

Report Scope & Overview:

Computerized polymerase chain response (dPCR) is utilized to partition an example of DNA or cDNA. Developing administrative drives in executing better atomic analytic strategies in sicknesses finding is expected to cultivate the development of the dPCR market. The computerized polymerase chain response (dPCR) market was esteemed at $331.42 Mn in 2021 and is assessed to reach $1183.32 Mn by 2028, developing at a CAGR of 19.89% during the estimated time frame 2021-2028. Europe holds the biggest offer in the market followed by Asia-Pacific attributable to the rising geriatric populace in these locales. Asia-Pacific is projected to observe the quickest development during the estimated time frame inferable from the rising R&D use in the existing sciences area in different emerging nations like China and India.

Digital PCR-dPCR Market

Market Dynamics:

KEY DRIVERS:
The improvement of convenient, reduced, and lab-on-chip PCR gadgets and the ongoing mechanical incorporation with the PCR processes are the central point driving the development of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market during the conjecture time frame. The developing speculations and accessibility of assets for PCR-based research and the rising occurrences of target irresistible sicknesses are driving the development of the worldwide Digital PCR (dPCR) and Real-time PCR (qPCR) Market.

OPPORTUNITIES: 

The base year of the review is 2021, with figure done up to 2028. The review presents an exhaustive investigation of the cutthroat scene, considering the pieces of the pie of the main organizations. It likewise gives data on unit shipments. These furnish the key market members with important business knowledge and assist them with understanding the future of the advanced PCR in medical care market. The evaluation incorporates the gauge, an outline of the cutthroat design, the portions of the overall industry of the contenders, as well as the market patterns, market requests, market drivers, market difficulties, and item examination. The market drivers and restrictions have been surveyed to comprehend their effect over the figure time frame. This report further distinguishes the critical open doors for development while additionally itemizing the vital difficulties and potential dangers. The vital areas of center incorporate the sorts and end clients of Digital PCR, and their particular applications in the medical care industry.

CHALLENGES: 

Makers need high introductory expenses to fabricate advanced PCR framework. Furthermore, high last gadget expenses and specialized impediments in advanced PCR framework, like restricted scope of identification, are limiting the Digital PCR Market development. Inadequate number of scientists and talented workers, and absence of capable information examination devices are frustrating the market development. Developing execution of least data for distribution of Quantitative Digital PCR Experiments for the autonomous assessment of exploratory information and complete exposure of all pertinent subtleties is testing the market development. Additionally high establishment costs related with dPCR is supposed to limit the development of the dPCR market during the conjecture time frame.

IMPACT OF COVID-19: 

The COVID-19 flare-up is expected to decidedly affect the development of the computerized PCR market as advanced PCR tests are utilized for determination of COVID-19 contamination. The ascent in predominance of COVID-19 contamination supports the development of market. For example, as per world wellbeing association (WHO) report, starting around 19 December 2021, north of 273 million cases and over 5.3 million passings have been accounted for worldwide. Also, expansion in number of committed COVID-19 analytic focuses further contributes in development of market.

The advanced PCR market size is portioned based on innovation, item type, application, end client, and district. By innovation, the market is sorted into bead computerized PCR (ddPCR), chip based advanced PCR, and BEAMing computerized PCR. Contingent upon item type, it is divided into computerized PCR frameworks, consumables and reagents, and programming and administrations. Based on application, it is isolated into research, clinical diagnostics, criminology, and others.

According to end client, it is separated into drugs and biotechnology enterprises, clinical demonstrative labs, and colleges and different associations.

Based on item type, the computerized PCR frameworks section ruled the market in 2020, and this pattern is supposed to go on during the conjecture time frame attributable to ascend sought after for atomic diagnostics in customized medication and new item send off. Nonetheless, the consumables and reagents portion is supposed to observe impressive development during the advanced PCR market figure period because of flood sought after for early conclusion and expansion in number of central participants to make consumable and reagents for computerized PCR.

By application, Depending on end client, the drugs and biotechnology businesses fragment was the significant patron in 2021 and is supposed to keep up with its lead during the conjecture time frame inferable from ascend in number of malignant growth patients. Be that as it may, the clinical analytic labs portion is supposed to observe impressive development during the estimate time frame because of expansion in number of clinical exploration communities and ascend in number of clinical preliminaries.

Market Segmentation:

By Technology

  • Droplet Digital PCR

  • Chip Based Digital PCR

  • Beaming Digital PCR

By  Product Type

  • Igital PCR Systems

  • Consumables And Reagents

  • Software And Services

By Application

  • Clinical Diagnostics

  • Forensic And Others

  • Research

By End-Use

  • Pharmaceuticals And Biotechnology Industries

  • Clinical Diagnostic Laboratories

  • Universities And Other Organizations

Digital PCR-dPCR Market

Key Market Players
Thermo Fisher Scientific,
Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, bioMérieux SA, Danaher Corporation, Eppendorf, Fluidigm Corporation, Merck KGaA, QIAGEN N.V., Takara Bio, Meridian Bioscience, Promega Corporation, Enzo Life Sciences, Inc., Bioneer, ELITech Group, Quidel Corporation, and Others.

REGIONAL COVERAGE:

North America

  • USA

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • The Netherlands

  • Rest of Europe

Asia-Pacific

  • Japan

  • south Korea

  • China

  • India

  • Australia

  • Rest of Asia-Pacific

The Middle East & Africa

  • Israel

  • UAE

  • South Africa

  • Rest of Middle East & Africa

Latin America

  • Brazil

  • Argentina

  • Rest of Latin America

 

Digital PCR-dPCR Market Report Scope:
Report Attributes Details
Market Size in 2021 US$ 331.42 Million
Market Size by 2028 US$ 1183.32 Million
CAGR CAGR of 19.89% From 2022 to 2028
Base Year 2021
Forecast Period 2022-2028
Historical Data 2017-2020
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Technology Type (Droplet Digital PCR, Chip Based Digital PCR, Beaming Digital PCR)
• By Product (Igital PCR Systems, Consumables and Reagents, Software And Services)
• By Application (Clinical Diagnostics, Forensic And Others)
• By End Use (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories, Universities And Other Organizations)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, bioMérieux SA, Danaher Corporation, Eppendorf, Fluidigm Corporation, Merck KGaA, QIAGEN N.V., Takara Bio, Meridian Bioscience, Promega Corporation, Enzo Life Sciences, Inc., Bioneer, ELITech Group, Quidel Corporation


Frequently Asked Questions (FAQ) :


Table of Contents

 

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

 

2. Research Methodology

 

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

 

4. Impact Analysis

4.1 COVID 19 Impact Analysis

 

5. Value Chain Analysis

 

6. Porter’s 5 forces model

 

7.  PEST Analysis

 

8. Digital PCR-dPCR Market Segmentation, by Technology type

8.1 Droplet Digital PCR

8.2 Chip Based Digital PCR

8.3 Beaming Digital PCR

 

9. Digital PCR-dPCR Market Segmentation, by Product type

9.1 Igital PCR Systems

9.2 Consumables And Reagents

9.3 Software And Services

 

10. Digital PCR-dPCR Market Segmentation, By application

10.1 Clinical Diagnostics

10.2 Forensic And Others

10.3 Research

 

11. Digital PCR-dPCR Market Segmentation, By End Use

11.1 Pharmaceuticals And Biotechnology Industries

11.2 Clinical Diagnostic Laboratories

11.3 Universities And Other Organizations

 

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.2  Canada

12.2.3  Mexico

12.3     Europe

12.3.1  Germany

12.3.2  UK

12.3.3  France

12.3.4  Italy

12.3.5  Spain

12.3.6  The Netherlands

12.3.7  Rest of Europe

12.4     Asia-Pacific

12.4.1  Japan

12.4.2  South Korea

12.4.3  China

12.4.4  India

12.4.5  Australia

12.4.6  Rest of Asia-Pacific

12.5     The Middle East & Africa

12.5.1  Israel

12.5.2  UAE

12.5.3  South Africa

12.5.4  Rest

12.6     Latin America

12.6.1  Brazil

12.6.2  Argentina

12.6.3  Rest of Latin America

 

13. Company Profiles

13.1Thermo Fisher Scientific

13.1.1 Financial

13.1.2 Products/ Services Offered

13.1.3 SWOT Analysis

13.1.4 The SNS view

13.2 Bio-Rad Laboratories Inc.,

13.3 Hoffmann-La Roche, Ltd. (Switzerland)

13.4 Abbott Laboratories

13.5 Agilent Technologies

13.6 Analytik Jena AG (Switzerland)

13.7 Becton Dikinson and Company

13.8 bioMérieux SA (France)

13.9 Danaher Corporation

13.10 Eppendorf (Germany)

13.11 Fluidigm Corporation

13.12 Merck KGaA  (Germany)

13.13 QIAGEN N.V.  (Netherlands)

13.14 Takara Bio (Japan)

13.15 Meridian Bioscience

13.16 Promega Corporation

13.17 Enzo Life Sciences, Inc.

13.18 Bioneer (South Korea)

13.19 ELITech Group (France)

13.20 Quidel Corporation.

 

14. Competitive Landscape

14.1 Competitive Benchmarking

14.2 Market Share analysis

14.3 Recent Developments

 

15.Conclusion

 

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.

Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.